These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 32457796)
21. Recent Advances in the Modeling of Alzheimer's Disease. Sasaguri H; Hashimoto S; Watamura N; Sato K; Takamura R; Nagata K; Tsubuki S; Ohshima T; Yoshiki A; Sato K; Kumita W; Sasaki E; Kitazume S; Nilsson P; Winblad B; Saito T; Iwata N; Saido TC Front Neurosci; 2022; 16():807473. PubMed ID: 35431779 [TBL] [Abstract][Full Text] [Related]
22. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology. Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769 [TBL] [Abstract][Full Text] [Related]
23. An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis. Caselli RJ; Knopman DS; Bu G Alzheimers Dement; 2020 Nov; 16(11):1582-1590. PubMed ID: 32588983 [TBL] [Abstract][Full Text] [Related]
24. The human β-amyloid precursor protein: biomolecular and epigenetic aspects. Nguyen KV Biomol Concepts; 2015 Mar; 6(1):11-32. PubMed ID: 25719338 [TBL] [Abstract][Full Text] [Related]
26. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1. Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309 [TBL] [Abstract][Full Text] [Related]
27. [From physiopathology to treatment of Alzheimer's disease]. Delacourte A Rev Neurol (Paris); 2006 Oct; 162(10):909-12. PubMed ID: 17028557 [TBL] [Abstract][Full Text] [Related]
28. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Gandy S; Petanceska S Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430 [TBL] [Abstract][Full Text] [Related]
29. Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease. Jiang S; Zhang M; Ren D; Tang G; Lin S; Qian Y; Zhang Y; Jiang K; Li F; Wang D Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):99-102. PubMed ID: 12627474 [TBL] [Abstract][Full Text] [Related]
30. The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment. Ma F; Akolkar H; Xu J; Liu Y; Popova D; Xie J; Youssef MM; Benosman R; Hart RP; Herrup K J Neurosci; 2023 Mar; 43(10):1830-1844. PubMed ID: 36717226 [TBL] [Abstract][Full Text] [Related]
31. Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease. Chen Y; Tian Z; Liang Z; Sun S; Dai CL; Lee MH; LaFerla FM; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX PLoS One; 2012; 7(12):e51432. PubMed ID: 23236499 [TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1). Neve RL; McPhie DL; Chen Y Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687 [TBL] [Abstract][Full Text] [Related]
33. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits. Triaca V; Ruberti F; Canu N Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297 [TBL] [Abstract][Full Text] [Related]
34. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593 [TBL] [Abstract][Full Text] [Related]
36. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060 [TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
38. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316 [TBL] [Abstract][Full Text] [Related]
39. The Y Matrone C; Iannuzzi F; Annunziato L Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414 [TBL] [Abstract][Full Text] [Related]
40. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease. Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]